‘Bridge to transplant’: Mini human livers grown in rats spurs research that could alleviate transplant shortage

d db c d c lab grown mini liver
A lab-grown mini liver originally derived from human skin cells in the team's bioreactor. Credit: University of Pittsburgh

Using skin cells from human volunteers, researchers at the University of Pittsburgh School of Medicine have created fully functional mini livers, which they then transplanted into rats.

In this proof-of-concept experiment, the lab-made organs survived for four days inside their animal hosts. These results were published [June 2] in Cell Reports.

“Seeing that little human organ there inside the animal – brown, looking like a liver – that was pretty cool. This thing that looks like a liver and functions like a liver came from somebody’s skin cells,” said senior author Alejandro Soto-Gutierrez.

These mini livers secrete bile acids and urea, just like a normal liver, except they’re made-to-order in the lab using patient cells.

In all cases, blood flow problems had developed within and around the graft, but the transplanted mini livers worked – the rats had human liver proteins in their blood serum.

Soto-Gutierrez is optimistic that this research is not merely a stepping-stone on the path toward growing replacement organs in a lab, but also a useful tool in its own right.

“The long-term goal is to create organs that can replace organ donation, but in the near future, I see this as a bridge to transplant,” Soto-Gutierrez said. “For instance, in acute liver failure, you might just need hepatic boost for a while instead of a whole new liver.”

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
ChatGPT-Image-Aug-4-2026-10_15_14-AM
Viewpoint—A hard look at the Fauci diaries: Do they change what we know about COVID’s origins?
ChatGPT-Image-Jul-31-2026-07_35_35-AM
Wikipedia has assembled an informative list of fake news websites from across the ideological spectrum
Screenshot-2026-07-31-at-10.52.03-AM
Love sweets and fatty foods? You can blame your genes, but there are ways to quell the obsessions
Screenshot-2026-08-03-at-2.25.49-PM
As measles vaccination rates collapse, scientists push for treatments long considered unnecessary
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
Screenshot-2026-08-03-at-2.15.16-PM
Viewpoint: Trump’s relaxed controls on supplying China with microchips could undermine U.S. AI dominance
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
ChatGPT Image Jul 29, 2026, 10_17_59 AM
Viewpoint: What does it mean when critics of conventional agriculture say many fruits and vegetables are “linked” to pesticide poisoning?
ChatGPT-Image-Aug-4-2026-09_31_50-AM-2
Viewpoint: Could the U.S. become dependent on China to develop critical new genetic and drug therapies?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.